Financials
- Market Capitalization 264.19 M
- Employee 34
- Founded 2004
- CEO Christopher U. Missling Ph.D.
- Website www.anavex.com
- Headquarter New York, United States
- FIGI BBG000C9K8K4
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-7.87
市销率
63.29
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 3405 | MGNX MacroGenics, Inc. - Common Stock | 4.25 USD | -1.62% | +4.68% | +8.42% | +114.65% | 270.73 M USD | ||
| 3419 | SRZN Surrozen, Inc. - Common Stock | 22.54 USD | -0.27% | -4.17% | +0.40% | +70.11% | 264.93 M USD | ||
| 3426 | WHWK Whitehawk Therapeutics, Inc. - Common Stock | 4.63 USD | -1.70% | -4.93% | +11.57% | +53.82% | 263.95 M USD | ||
| 3437 | YDES YD Bio Limited - Ordinary Shares | 3.67 USD | -5.90% | -6.85% | +63.11% | -75.20% | 259.80 M USD |